Fundies.
English

FRESENIUS MEDICAL CARE AG & Co. KGaA

EDGAR
FMCQF Report (type unavailable) · filed 2026-10-07

Annual consolidated revenue for 2025: about Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 19.63B, using the latest reported figures. The previous period, 2024, was about Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 19.34B.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

4.86 billion Unit_Standard_EUR_4UFxkwQcsU2KXR_lmoTWPg

2026 Q2 · Unit_Standard_EUR_4UFxkwQcsU2KXR_lmoTWPg

Exact inputs and evidence
  • Revenue: 4860566000 Unit_Standard_EUR_4UFxkwQcsU2KXR_lmoTWPg Source

Operating margin

9.58%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: 465855000 Unit_Standard_EUR_4UFxkwQcsU2KXR_lmoTWPg Source
  • Revenue: 4860566000 Unit_Standard_EUR_4UFxkwQcsU2KXR_lmoTWPg Source
Cash and cash equivalents
1.06 billion Unit_Standard_EUR_4UFxkwQcsU2KXR_lmoTWPg Source
Exact value

1061251000 Unit_Standard_EUR_4UFxkwQcsU2KXR_lmoTWPg

Long-term debt including current maturities
Not available
Shares outstanding
306 million shares Source
Exact value

306221840 shares

Reported share-count change

0.30% · 908 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 305314120 shares · 2015-12-31· Source
  • 306221840 shares · 2016-12-31· Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-07.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2025-12-31
  • Operating income: 3 of 11 periods available· newest 2025-12-31
  • Net income: 3 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 5 of 11 periods available· newest 2019-12-31
  • Total assets: Multiple units; comparison withheld· newest 2025-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Current assets: Multiple units; comparison withheld· newest 2025-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 2 of 11 periods available· newest 2016-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +1.5%

    Prior period

    Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 19.34 billion

    –

    Current period

    Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 19.63 billion

    –

    Exact inputs and evidence

    19627602000 − 19335909000 = 291693000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ

    19335909000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    19627602000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +81.9%

    Prior period

    Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 537.91 million

    –

    Current period

    Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 978.37 million

    –

    Exact inputs and evidence

    978367000 − 537913000 = 440454000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ

    537913000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    978367000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +12.4%

    Prior period

    Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 2.39 billion

    –

    Current period

    Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 2.68 billion

    –

    Exact inputs and evidence

    2680999000 − 2386144000 = 294855000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ

    2386144000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    2680999000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 19.63 billion 100% of revenue
  • Cost of revenue Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 14.6 billion 74% of revenue
  • Operating expenses Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 3.19 billion 16% of revenue
  • Operating income Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 1.83 billion 9.3% of revenue
  • Tax, interest and other Derived Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 848.67 million 4.3% of revenue
  • Net income Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 978.37 million 5% of revenue

Cash

  • Operating cash flow Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 2.68 billion 14% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2023 93%
  • 2024 93%
  • 2025 91%
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2023 2023-01-01 – 2023-12-3119453617000 18084179000 Derived 1369438000 870441000 Derived 498997000 Unavailable
Source
2024 2024-01-01 – 2024-12-3119335909000 17943514000 Derived 1392395000 854482000 Derived 537913000 Unavailable
Source
2025 2025-01-01 – 2025-12-3119627602000 17800566000 Derived 1827036000 848669000 Derived 978367000 Unavailable
Source

Amounts are exact, in Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 19.6B 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.21.2B15.9B10.6B5.3B0.0202320242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ)Source evidence
2023Revenue19453617000
2024Revenue19335909000
2025Revenue19627602000

Revenue growth

Change in revenue from the same financial period one year earlier.

1.5% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.68%1.06%0.45%-0.16%-0.77%202320242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2023Year over yearNo prior comparable period
2024Year over year-0.6%
2025Year over year1.5%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 9.3% 2025
Net margin 5% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.10.1%7.5%5.0%2.5%0.0%202320242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2023Operating margin7%
2024Operating margin7.2%
2025Operating margin9.3%
2023Net margin2.6%
2024Net margin2.8%
2025Net margin5%
2023Free cash flow marginNot reported
2024Free cash flow marginNot reported
2025Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 2.7B 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.9B2.2B1.4B723.9M0.0202320242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ)Source evidence
2023Operating cash flow2628801000
2024Operating cash flow2386144000
2025Operating cash flow2680999000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ)Source evidence
2023Free cash flowUnavailable
2024Free cash flowUnavailable
2025Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2023-12-31Liabilities / assetsNot reportedNo source recorded
2024-12-31Liabilities / assetsNot reportedNo source recorded
2025-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2023-12-31Current assets / current liabilitiesNot reportedNo source recorded
2024-12-31Current assets / current liabilitiesNot reportedNo source recorded
2025-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2023 2023-01-01 – 2023-12-31
Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 499 million
Exact value

Exact value: 498997000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ

2023-01-01 – 2023-12-31: 498997000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 2.63 billion
Exact value

Exact value: 2628801000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ

2023-01-01 – 2023-12-31: 2628801000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2024 2024-01-01 – 2024-12-31
Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 537.91 million
Exact value

Exact value: 537913000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ

2024-01-01 – 2024-12-31: 537913000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 2.39 billion
Exact value

Exact value: 2386144000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ

2024-01-01 – 2024-12-31: 2386144000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2025 2025-01-01 – 2025-12-31
Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 978.37 million
Exact value

Exact value: 978367000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ

2025-01-01 – 2025-12-31: 978367000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ 2.68 billion
Exact value

Exact value: 2680999000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ

2025-01-01 – 2025-12-31: 2680999000 Unit_Standard_EUR_8pwkQ7QdQE-IXdtdESUZpQ Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

371 filings · 9,679 latest values · 9,679 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001333141, 1333141, FMCQF, FMS, edgar:1333141

Also known as FRESENIUS MEDICAL CARE AG, FRESENIUS MEDICAL CARE AG & Co. KGaA, FRESENIUS MEDICAL CARE AG & Co. KGaA, Fresenius Medical Care AG, Fresenius Medical Care AG & Co. KGaA